JP2004527567A5 - - Google Patents

Download PDF

Info

Publication number
JP2004527567A5
JP2004527567A5 JP2002586947A JP2002586947A JP2004527567A5 JP 2004527567 A5 JP2004527567 A5 JP 2004527567A5 JP 2002586947 A JP2002586947 A JP 2002586947A JP 2002586947 A JP2002586947 A JP 2002586947A JP 2004527567 A5 JP2004527567 A5 JP 2004527567A5
Authority
JP
Japan
Prior art keywords
keto
compound
composition
prostaglandin
prostaglandin compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002586947A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004527567A (ja
JP4332353B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/004223 external-priority patent/WO2002089812A1/en
Publication of JP2004527567A publication Critical patent/JP2004527567A/ja
Publication of JP2004527567A5 publication Critical patent/JP2004527567A5/ja
Application granted granted Critical
Publication of JP4332353B2 publication Critical patent/JP4332353B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002586947A 2001-05-02 2002-04-26 15−ケト−プロスタグランジン類を含む薬物誘発性便秘処置用組成物 Expired - Fee Related JP4332353B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28772001P 2001-05-02 2001-05-02
PCT/JP2002/004223 WO2002089812A1 (en) 2001-05-02 2002-04-26 Composition for treating drug-induced constipation with 15-keto-prostaglandins

Publications (3)

Publication Number Publication Date
JP2004527567A JP2004527567A (ja) 2004-09-09
JP2004527567A5 true JP2004527567A5 (enExample) 2005-11-17
JP4332353B2 JP4332353B2 (ja) 2009-09-16

Family

ID=23104042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002586947A Expired - Fee Related JP4332353B2 (ja) 2001-05-02 2002-04-26 15−ケト−プロスタグランジン類を含む薬物誘発性便秘処置用組成物

Country Status (19)

Country Link
US (1) US6982283B2 (enExample)
EP (1) EP1392318B1 (enExample)
JP (1) JP4332353B2 (enExample)
KR (1) KR100886598B1 (enExample)
CN (1) CN1522147B (enExample)
AR (2) AR035237A1 (enExample)
AT (1) ATE355067T1 (enExample)
AU (1) AU2002251554B2 (enExample)
BR (1) BR0209327A (enExample)
CA (1) CA2444103C (enExample)
DE (1) DE60218451T2 (enExample)
DK (1) DK1392318T3 (enExample)
ES (1) ES2282408T3 (enExample)
MX (1) MXPA03010019A (enExample)
NO (1) NO335143B1 (enExample)
NZ (1) NZ529187A (enExample)
PT (1) PT1392318E (enExample)
TW (1) TWI302100B (enExample)
WO (1) WO2002089812A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4786866B2 (ja) 2001-08-31 2011-10-05 スキャンポ・アーゲー クロライドチャンネルオープナーとしてのプロスタグランジンアナログ
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
ES2379652T3 (es) * 2002-10-23 2012-04-30 Sucampo Ag Compuestos de prostaglandina para el tratamiento de obesidad
JP4889219B2 (ja) 2002-12-27 2012-03-07 スキャンポ・アーゲー 腹部不快感の処置のためのプロスタグランジン誘導体
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
MX2007010833A (es) * 2005-03-07 2009-02-17 Univ Chicago Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
KR101466980B1 (ko) * 2005-04-12 2014-12-01 수캄포 아게 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자펌프 억제제의 병용
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
WO2009059307A1 (en) * 2007-11-01 2009-05-07 Washington University In St. Louis Compositions and methods for treating pruritus
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US8957024B2 (en) 2011-07-27 2015-02-17 Washington University Composition and methods for reducing opioid-induced pruritus
KR20140052389A (ko) 2012-10-24 2014-05-07 주식회사 아리바이오 해양 심층수 또는 염지하수로부터 제조된 고경도의 미네랄 워터를 포함하는 변비 예방, 개선 또는 치료용 조성물
US20140116916A1 (en) 2012-10-31 2014-05-01 2294719 Ontario Limited Therapy for Constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
CN105777601A (zh) * 2014-12-26 2016-07-20 中国人民解放军第二军医大学 一种前列地尔衍生物及其药物制剂
JP2019513355A (ja) * 2016-03-29 2019-05-30 コロナリーコンセプツ エルエルシー 便秘症を処置するための製剤
US11534404B2 (en) 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
EP0310305B1 (en) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW249226B (enExample) 1990-04-04 1995-06-11 Aderk Ueno Kk
DE69130586T2 (de) * 1990-05-01 1999-06-17 R-Tech Ueno, Ltd., Osaka Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
KR19990036322A (ko) 1996-06-10 1999-05-25 류지 우에노 엔도텔린길항제
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
BR0209863A (pt) * 2001-05-18 2004-06-08 Sucampo Ag Composição catártica

Similar Documents

Publication Publication Date Title
JP2008531468A5 (enExample)
DK2592081T3 (en) TETRAHYDROCARBOLIN DERIVATIVES
CA2600331A1 (en) Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
CA2444103A1 (en) Composition for treating drug-induced constipation with 15-keto-prostaglandins
JP2005504836A5 (enExample)
JP2009521483A5 (enExample)
JP2006521359A5 (enExample)
RU2002103597A (ru) Композиция для лечения нарушений внешней секреции
JP2006513232A5 (enExample)
JP2004507521A5 (enExample)
JP2011516511A5 (enExample)
EA200970582A1 (ru) ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5Н-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH
US6818638B2 (en) Melvinolin derivatives
RU2018113296A (ru) Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения
JP2004529960A5 (enExample)
JP2006506381A5 (enExample)
JP2008533195A5 (enExample)
JP2008528440A5 (enExample)
JP2007518685A5 (enExample)
JP2004519412A5 (enExample)
JP4990620B2 (ja) 7−置換カンプトテシンおよびカンプトテシン類似体ならびにそれらの調製方法
CA2445651A1 (en) Cathartic composition comprising halogenated prostaglandin derivatives
RU2006122935A (ru) Новые производные бензимидазола и имидазопиридина и их применение в качестве лекарственных средств
RU2440338C2 (ru) Способ и композиция для лечения заболеваний центральной нервной системы
JP2006518765A5 (enExample)